Tag Archives: GSK

Pharma’s Foreign Corrupt Practices Accompany Its Domestic Violations

Worst Pills Best Pills Newsletter article October, 2013 Between 1991 and mid-2012, U.S. drug companies paid a total of more than $30 billion for domestic criminal or civil violations, including withholding safety information from the Food and Drug Administration (FDA), … Continue reading

Posted in Pharmaceutical Promotion | Tagged , , , , , , , , | Leave a comment

GSK cops $3 bn fine for largest health care fraud in US; 17th Edition of Medicines Australia Code released

Not surprisingly, these two news items led to a discussion on Australian television (and elsewhere) of whether the promotional activities of the pharmaceutical industry should be governed by self-regulatory industry codes of conduct or by co-regulation involving the government and … Continue reading

Posted in Pharmaceutical Promotion | Tagged , , , , , , , | Leave a comment